Follow Pharmaceutical Processing Online!
Pharmaceutical Processing® (ISSN #1049-9156, USPS #001-314), is published seven times a
year. Bi-monthly in Jan/Feb, Apr/May, Jul/Aug, Sep/Oct, Nov/Dec monthly in Mar & Jun by Advantage
Business Media, 100 Enterprise Drive, Suite 600, Rockaway, NJ 07866. No part of this publication
may be reproduced in any form without prior written permission of the publisher. Opinions expressed in
articles are those of the authors and do not necessarily reflect those of Advantage Business Media.
Periodicals Mail postage paid at Rockaway, NJ 07866 and at additional mailing offices.
POSTMASTER: Send address changes/cancellations to Pharmaceutical Processing, 100 Enterprise
Drive, Suite 600, Rockaway, NJ 07866-0912, email: ABM_return@advantagemedia.com. Publications
Mail Agreement No. 41336030. Return undeliverable Canadian addresses to: Imex/Pitney Bowes, P.O.
Box 1632, Windsor Ontario N9A 7C9.
Subscriptions are free to qualified individuals.
Printed in USA: Every attempt is made to ensure the accuracy of the information contained herein,
however Advantage Business Media and its employees cannot accept responsibility for the correctness
of information supplied, advertisements, or opinions expressed. Copyright ©2018 Advantage Business
Media. All rights reserved.
Michael J. Beier,
Senior Vice President of Operations
TITAN PHARMACEUTICALS, INC.
Dr. James V. Blackwell, PhD, Consultant
BIOPROCESS TECHNOLOGY CONSULTANTS,
Ronald C. Branning,
Vice President Global Quality
Robert F. Dream, Vice President
H.D.R. COMPANY LTD.
Johanna Carmel Egan,
VGP Project Management
Girish Malhotra, President
Allan F. Pfitzenmaier, President
VECTECH PHARMA CONSULTANTS INC.
Susan Polizzotto, Manager,
R&D QA GMP Compliance
US SANOFI PASTEUR
Sr. Dir. Global Engineering
Richard G. Whitfield, Senior Director
Patrick Wong, Director of Global Engineering
BRISTOL-MYERS SQUIBB (BMS)
For subscription related matters please
contact us at:
Setting the Stage for 2019
While much of the attention in pharma continues to
focus on the upcoming serialization deadlines, there
are numerous other efforts well underway that aim to
advance the safety, development, and availability of
In this month’s issue, we examine several of
those efforts, including tech moves to increase
manufacturing flexibility, new and creative uses of
artificial intelligence in life sciences, the need for
better access to research specimens, and how an
“intelligent” inhaler from 3M can monitor correct
patient dosages and adherence to assure maximum
Our cover article examines io.Equipment, a new
system based on blockchain technology that places
a verifiable and tamperproof “fingerprint” that can
be recorded in a digital log book for all equipment
operations. It uses a methodology that keeps records
strictly confidential, while still providing proof that
the data actually exists.
In an interview with Pharmaceutical Processing,
Andreas Eschbach, CEO and founder of eschbach
GmbH, estimates that in the U.S. alone, there are
more than a half million paper log books actively
used in the pharmaceutical
industry. That’s a recipe
for human error. See how
io.Equipment and blockchain
can fix that. Our cover story
begins on page 10.
‘Fine’ Times Ahead?
Of course, as we head toward the expiration of the
year-long FDA reprieve from enforcement of noncompliance fines in connection with the DSCSA,
Pharmaceutical Processing will continue to keep a close
eye on where the industry stands on the issue.
Some in the community say that a number of
companies still have much work to do to become
compliant. With only four months to go, that could
spell big trouble for procrastinators.
PharmPro.com, as always, will continue to provide
updates on the race toward serialization, along
with thought-provoking insight and late-breaking
pharmaceutical news from throughout the U.S.,
Europe, Asia, and elsewhere.
To stay up to date, be sure to subscribe to our free
daily e-newsletter and companion digital services. It’s
quick and easy at subscriptions.pharmpro.com.
— Mike Botta